HP and melanoma: It is probable that high baseline levels of fecal SIgA and zonulin may reflect overall melanoma-induced activation of the immune system, which may favor efficacy of the immunotherapy, while low levels of these biomarkers at baseline may mirror immune exhaustion or immunosuppression that may negatively impact clinical outcomes of ICIs.